Work

The association of toxicities and outcomes with circulating endothelial cells (CEC) in non-small cell lung cancer (NSCLC) patients (pts) treated with bevacizumab (Bev).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e19012

Authors: Nooshin Hashemi Sadraei, Lingling Du, Ruchi Yadav, Ronald Grane, Barbara Jacobs, John Hamulak, Patrick C. Ma, Nathan A. Pennell, Paul Elson, Ernest C. Borden

Institutions: Cleveland Clinic, Case Comprehensive Cancer Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599262086

Cites:

Cited by:

Related to: 10